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Aromatase in the mouse brain is expressed only in the nerve cells of speciﬁc brain regions
with a transient peak during the neonatal period when sexual behaviors become orga-
nized.The aromatase-knockout (ArKO) mouse, generated to shed light on the physiological
functions of estrogen in the brain, exhibited various abnormal behaviors, concomitant with
undetectable estrogen and increased androgen in the blood.To further elucidate the effects
of neurosteroidal estrogens on behavioral phenotypes, we ﬁrst prepared an brain-speciﬁc
aromatase transgenic (bsArTG) mouse by introduction of a human aromatase transgene
controlled under a −6.5 kb upstream region of the brain-speciﬁc promoter of the mouse
aromatase gene into fertilized mouse eggs, because the −6.5 kb promoter region was
previously shown to contain the minimal essential element responsible for brain-speciﬁc
spatiotemporal expression. Then, an ArKO mouse expressing the human aromatase only
in the brain was generated by crossing the bsArTG mouse with the ArKO mouse. The
resulting mice (ArKO/bsArTG mice) nearly recovered from abnormal sexual, aggressive,
and locomotive (exploratory) behaviors, in spite of having almost the same serum levels
of estrogen and androgen as the adult ArKO mouse.These results suggest that estrogens
locally synthesized in the speciﬁc neurons of the perinatal mouse brain directly act on the
neurons and play crucial roles in the organization of neuronal networks participating in the
control of sexual, aggressive, and locomotive (exploratory) behaviors.
Keywords: knockout mouse, transgenic mouse, brain-specific expression, aromatase, estrogen, androgen, sexual
behavior
INTRODUCTION
Aromatase (the cyp19 gene product) is a key enzyme in the biosyn-
thesis of estrogen from androgen. It is localized not only in the
gonads but also in the brains of vertebrates from ﬁsh to mammals
and plays important roles in the brain sexual differentiation and
in the sexual behaviors through paracrine or autocrine actions
of estrogen as a neurosteroid. Aromatase in the mouse brain is
expressed only in the nerve cells of speciﬁc brain regions including
the hypothalamus and limbic areas with a transient peak during
the neonatal period when neuronal networks and imprinting of
sexual behaviors are irreversibly organized (Balthazart et al., 1991;
Harada and Yamada, 1992; Lauber and Lichtensteiger, 1994).
An essential direct-acting factor in the processes of sexual
differentiation of the brain was formerly considered to be testos-
terone (T) secreted from the testes during the perinatal period
(Beach, 1946; Pfaff, 1970). However, dihydrotestosterone (DHT),
a biologically active androgen, was unable to restore impaired
male sexual behaviors in castrated rats (McDonald et al., 1970).
Moreover, some antiestrogens and aromatase inhibitors blocked
androgen-induced sexual behaviors in male rats (Christensen and
Clements, 1975; Beyer et al., 1976). Then, Naftolin et al. (1972)
proposed an aromatase hypothesis, in which brain aromatase
would be responsible for the organization of the neural circuitry
underlying male sexual behaviors by conversion of T from fetal
testes to 17β-estradiol (E2) in the brain (MacLusky and Naftolin,
1981).
Experimental model animals exhibiting estrogen or androgen
deﬁciency were generated in mice by targeted disruption of estro-
gen receptors (ERs), androgen receptor (AR), and aromatase genes
and the roles of neurosteroids were studied in reproductive phys-
iology and behavior. A series of studies on the knockout mice of
ERα (αERKO),ERβ (βERKO),or both of ERα andβ (αβERKO)has
revealed that ERs play essential roles in male sexual behaviors as
well as aggressive and parental behaviors (Ogawa et al., 1997, 1999,
2000;Wersinger et al., 1997). On the other hand, conditionalArKO
mice generated by a Cre-lox system also exhibited impaired sexual
and aggressive behaviors in males and normal sexual behaviors
in females, suggesting that androgen/AR are required for perina-
tal brain masculinization (Sato et al., 2004). Aromatase-knockout
(ArKO) mice generated by several groups (Fisher et al., 1998;
Honda et al., 1998; Toda et al., 2001c) had impaired reproduc-
tive functions, glucose/lipid metabolisms, and socio-emotional or
sexual behaviors.
Aromatase-knockout mice showed accumulation of androgen
aswell as a deﬁciency of estrogen in the blood. Consequently, accu-
mulated T is converted to DHT, a ligand of AR, by 5α-reductase.
DHT is further metabolized to 5α-androstan-3β, 17β-diol by 3β-
hydroxysteroid dehydrogenase (3β-HSD) and 17β-hydroxysteroid
dehydrogenase (17β-HSD). Accumulated T is also converted to
dehydroepiandrosterone (DHEA) and 5α-androsten-3β, 17β-diol
by 3β-HSD, and 17β-HSD. Recently, 5α-androsten-3β, 17β-diol,
and 5α-androstan-3β, 17β-diol were shown to be good ligands for
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ERα and ERβ, and to exert physiological functions in the brain
(Lund et al., 2006; Jellinck et al., 2007). The metabolic side effects
accompanied by the aromatase gene disruption and consequent
genomic effects through activation of nuclear receptors by binding
of androgenmetabolites shouldbe considered in the interpretation
of the aberrant phenotypes of ArKO mice.
We have already identiﬁed the promoter region responsible for
the brain-speciﬁc spatiotemporal expression of the mouse aro-
matase gene in a previous study (Harada and Honda, 2005). In
this study, we generated an ArKO mouse expressing the human
aromatase gene only in the brain [ArKO/ brain-speciﬁc aromatase
transgenic (bsArTG) mouse] by introduction of the aromatase
transgene controlled under a brain-speciﬁc promoter. We com-
pared the behavioral phenotypes with those of the ArKO mouse
as an approach to elucidate the effects of estrogen deﬁciency
separately from the effects of androgen metabolites.
MATERIALS AND METHODS
ANIMALS
Aromatase-knockoutmicewere generatedbypairingheterozygous
mutant animalswhichwere generatedby targeteddisruptionof the
aromatase gene (Honda et al., 1998). The crossings were repeated
over 20 generations to generate ArKO offspring with a genetic
background of C57BL/6. The transgenic mice brain-speciﬁcally
expressing human aromatase (bsArTG mice) were generated by
microinjection of the aromatase transgene controlled under the
brain-speciﬁc promoter of the mouse aromatase gene into fertil-
ized eggs (Gorski et al., 1986; Harada and Honda, 2005). Genomic
DNA was prepared from the tails of the offspring, and screened
by polymerase chain reaction (PCR) to select ArKO and bsArTG
mice. TheArKO/bsArTGmousewas prepared by pairing theArKO
with bsArTG mouse. Mice were singly housed under a controlled
photoperiodwith a 12:12-h light–dark cycle and temperature (22–
24˚C) throughout the tests with food and water available ad libi-
tum. Animal care and experiments were conducted in accordance
with Fujita Health University guidelines.
BEHAVIORAL ANALYSES
Behavioral analyses of sexual behaviors (mount, intromission,
and ejaculation), aggressive behaviors (tail rattling, chasing, box-
ing, biting, offensive attach, wrestling), infanticide behavior, and
locomotive (exploratory) behavior were performed as described
previously (Matsumoto et al., 2003b). All behavioral tests were
conducted during the dark phase of the light/dark cycle start-
ing at 2 h after lights were switched off and video-recorded with
infrared night scope for 15–30min each. Male mice were tested
for sexual behaviors during a 30-min test with estrous female
mice (C57BL/6). As stimuli, the female mice were ovariectomized
and injected with E2 benzoate (30 and 15μg at 48 and 24 h
before tests) and progesterone (500μg at 4–7 h before tests).
Males were also tested in their home cage against a group-
housed olfactory-bulbectomized male intruder mouse (C57BL/6)
for 15min. For each male tested, the total number of aggressive
bouts was scored. An aggressive bout was deﬁned as a consecutive
series of behavioral acts separated by less than 3 s. The locomo-
tive (exploratory) behavior was video-recorded in the open ﬁeld
cage (53 cm long× 35 cm wide× 30 cm high) with an infrared
night scope, and analyzed with travel distance, resting time, and
parallelism index as parameters using behavior analysis software
SMART (Panlab, S. L., Barcelona, Spain).
CONSTRUCTION OF TRANSGENES
The DdeI and StuI fragment of the human aromatase cDNA,
which contains a 5′-non-coding region of 19 bp, a complete cod-
ing region, and 3′-non-coding region of 303 bp, with a SV40
polyadenylation signal at the 3′-end was inserted into pUC118.
Then, the −6.5 kb promoter region of the brain-speciﬁc exon 1f
of the mouse aromatase gene (Harada and Honda, 2005) was
prepared from genomic DNA and inserted into the plasmid to
construct the bsArTG as shown in Figure 1. The transgene plas-
mid was linearized by Not I digestion, and used to generate the
bsArTG mouse as described previously (Hogan et al., 1994). Four
to six transgenic founders were obtained and maintained to gen-
erate progeny. Genomic DNA was prepared from the tails of the
offspring and screened for the presence of the transgene by PCR
(Honda et al., 1998).
ANALYSIS OF EXPRESSION OF THE AROMATASE TRANSGENE BY
REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION
The expression of the aromatase transgene in the ArTG or
ArKO/bsArTG mice were examined by RT–PCR of the total
RNAs which were prepared from tissue homogenates of ArTG or
ArKO/bsArTG mice. The oligonucleotides of an antisense primer
(5′-AACCACGATAGCACTTTGT-3′) for reverse transcription
(RT) and nested antisense- (5′-TGTTAGAGGTGTCCAGCATG-
3′) and sense- (5′-TACTACAACCGGGTATATGG-3′) primers for
PCR were synthesized. All were speciﬁc primers for the human
aromatase transgene, but not for the mouse aromatase gene. The
RT–PCR was performed as described previously (Honda et al.,
1998).
FIGURE 1 | Construction of the brain-specific aromatase transgene. (A)
The amino acid sequence of mouse aromatase is coded from the ATG
translational start site in the exon 2 to termination codon in exon 10 of the
gene. The exon 1f, ﬂanked with brain-speciﬁc regulatory elements in the
promoter region, is brain-speciﬁcally selected among multiple exons 1 of
the gene. (B)The brain-speciﬁc aromatase transgene was constructed by
linking human aromatase cDNA with the −6.5-kb promoter region of the
brain-speciﬁc exon 1f. (C–E)Tissue total RNAs were prepared from testes,
ovaries, kidneys, livers, and brains of ArTG mice (8–10 weeks of age)
carrying the brain-speciﬁc aromatase transgene and subjected to RT–PCR
speciﬁc for human aromatase in the presence (C) or absence (D) of reverse
transcriptase. As controls, RT–PCRs speciﬁc for β-actin (E) were also
performed.
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ASSAY OF SERUM LEVELS OF E2 AND T
The serum levels of E2 andTwere determinedby radio immunoas-
say (RIA; Mitsubishi Kagaku Bio-Clinical Laboratories, Inc.,
Tokyo) and enzyme immunoassay kits (Pantex, Santa Monica,
CA, USA). After anesthetization, 3–4 animals of each genotype
at 12–15weeks of age were used to collect the blood by cardiac
puncture. The serum samples were pooled and used for assays
of serum steroids, which were performed in triplicate for each
genotype.
STATISTICAL ANALYSIS
The frequency (mean± SEM) of mount, intromission, and ejac-
ulation behaviors was analyzed by a two-way analysis of variance
(ANOVA) with repeated measures followed by post hoc com-
parisons using the Fisher’s protected least signiﬁcant difference
(Fisher’s PLSD) test. Differences in the incidences of behaviors
were analyzed by the χ2 test or Fisher’s exact probability test. We
considered differences signiﬁcant, if p-values< 0.05.
RESULTS
GENERATION AND CHARACTERIZATION OF THE ArKO/bsArTG MOUSE
The aromatase transgene expressing the human aromatase tran-
scriptionally regulated by the −6.5-kb promoter region of the
brain-speciﬁc exon 1f of the mouse aromatase gene (Figure 1)
was constructed and introduced into fertilized eggs to gener-
ate the bsArTG mouse. The ArKO/bsArTG mouse was prepared
by pairing of an ArKO with a bsArTG mouse. The resulting
ArKO/bsArTG mice exhibited the brain-speciﬁc expression of
the aromatase transgene (Figure 1). The expression was unde-
tectable in the testes, ovary, kidney, and liver of ArKO/bsArTG
mice. ArKO/bsArTG mice showed almost the same serum levels
of E2 and T as the ArKO mice (Table 1). The serum levels of
E2 in wild females were changed from <5 to 30 pg/ml accord-
ing to the estrous cycle in the ovary, whereas those of ArKO and
ArKO/bsArTG females were below the detection limit (<5 pg/ml).
The levels of T were 7.98 ng/ml in wild-type males and 0.21 ng/ml
in wild-type females and were signiﬁcantly increased in ArKO and
ArKO/bsArTG females. There were no signiﬁcant differences in T
levels between ArKO and ArKO/bsArTG mice (Table 1).
RESTORATION OF IMPAIRED BEHAVIORS IN ArKO MICE BY
INTRODUCTION OF bsArTG
Aromatase-knockout mice exhibited impairments of various
behaviors, such as sexual behaviors of mount, intromission, and
ejaculation, aggressive behaviors of tail rattling, chasing, boxing,
biting, offensive attack, and wrestling, infanticide behavior, and
locomotive (exploratory) behaviors as shown in Figures 2–7.
Wild-type males normally displayed frequent mount and intro-
mission, and ejaculation behaviors. In contrast, the frequency
of mount and intromission behaviors in the ArKO males were
observed at rates of 9 and 3% of the wild-type males’, respectively,
and no ejaculation was observed in the ArKO males (Figure 2).
However, the ArKO/bsArTG males almost completely recovered
from the impaired ejaculation behavior observed in the ArKO
males, whereas they signiﬁcantly but incompletely recovered from
the impaired behaviors of mount and intromission in the ArKO
males, compared with the same behaviors in the wild-type males.
ArKO/bsArTG males signiﬁcantly recovered from disorders in
the sexual behaviors of mount, intromission, and ejaculation
(Figure 2). Similarly, theArKOmales showed signiﬁcantly reduced
aggressive behaviors against an olfactory-bulbectomized male
intruder and simultaneously elevated aggression toward an estrous
female, while wild-type males attack a male intruder and accept
an estrous female (Figure 3). The ArKO/bsArTG males com-
pletely lacked the aggressive behavior to females in the same cage,
whereas they showed partial recovery of the decreased aggressive-
ness to the intruder males but not complete recovery, compared
with the wild-type males (Figure 3). Frequent infanticide behav-
iors were observed in ArKO males, whereas wild-type males did
not show any infanticide (Figure 4). The infanticide behavior
observed in the ArKO males almost completely disappeared in
the ArKO/bsArTG males as in the wild-type males (Figure 4).
The locomotive (exploratory) behavior was observed in the
open ﬁeld with regard to parameters of travel distance, rest-
ing time, and parallelism index. We analyzed video-monitored
locomotive (exploratory) behaviors of wild-type, ArKO, and
ArKO/bsArTG mice using behavioral analysis software, SMART
(Panlab). The spontaneous locomotive behavior of ArKO/bsArTG
mice was compared to that of wild-type and ArKO mice. We
observed that ArKO mice walked a few steps and looked around,
whereas wild-type and ArKO/bsArTG mice moved more linearly.
Time-series data of ArKO and wild-type mice at 200-ms intervals
revealed that wild-type mice moved around constantly whereas
ArKO mice move intermittently with some resting time, occa-
sionally with resting time of more than 1min (Figure 5). Con-
sequently, the shorter travel distance and the longer resting time
were observed in ArKO females, compared with wild-type and
ArKO/bsArTG females, whereas there were no signiﬁcant changes
Table 1 | Serum concentrations of E2 andT in the wild-type, ArKO, and ArKO/bsArTG mice.
Male Female
E2 (pg/ml) T (ng/ml) E2 (pg/ml) T (ng/ml)
Wild-type <5–15 7.98±8.66 <5–30 0.21±0.13
ArKO <5 9.57±8.95 <5 2.77±1.18
ArKO/bsArTG <5 9.77±9.92 <5 1.97±1.47
The serum concentrations of E2 andT were determined in males and females of wild-type, ArKO, and ArKO/bsArTGmice (n=3–4 each of 12–15weeks).The detection
limit of E2 was set to be 5 pg/ml from the standard titration curve.
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FIGURE 2 | Impairment and restoration of male sexual behaviors in
ArKO andArKO/bsArTG mice, respectively.The behavioral tests were
performed using wild-type (n=9), ArKO (n=11), and ArKO/bsArTG (n=9)
male mice aged 11–13weeks. The frequency of mount, intromission, and
ejaculation during a 30-min test was examined in the wild-type (solid bars),
ArKO (open bars), and ArKO/bsArTG (hatched bars) mice. An insert is a
enlarged graph of the ejaculation frequency. The frequency of each behavior
is indicated by the mean±SEM. Signiﬁcant differences of wild-type vs.
ArKO (impairments) and ArKO vs. ArKO/bsArTG (restorations) are shown
(*p <0.01).
FIGURE 3 |The resident intruder paradigm test of aggressive behaviors
in wild-type (n=9), ArKO n=11), and ArKO/bsArTG (n=9) male mice
aged 12–14weeks.The test male was examined in his home cage as the
resident against a group-housed olfactory-bulbectomized male intruder (A)
or an estrous female (B). The frequency of each aggressive behavior is
indicated by the mean±SEM. Signiﬁcant differences of wild-type vs. ArKO
and ArKO vs. ArKO/bsArTG are shown (*p <0.01).
of the travel distance and the resting time among wild-type,
ArKO, andArKO/bsArTGmales (Figure 6). The parallelism index,
another parameter of locomotor activity, indicated characteristic
features of movement in the open ﬁeld of these animals (Figure 7).
This parallelism index was signiﬁcantly lower in ArKO mice,
compared to the wild-type and ArKO/bsArTG mice (Figure 7).
DISCUSSION
Aromatase is tissue-speciﬁcally regulated by alternative utiliza-
tion of multiple exons 1 of the gene (Means et al., 1991; Harada
et al., 1993; Mahendroo et al., 1993). In the brain, aromatase is
FIGURE 4 | Infanticide behaviors in wild-type (n=9), ArKO (n=11), and
ArKO/bsArTG (n=9) mice aged 13–15weeks.The incidence of the
infanticide behavior is shown as a percentage, and statistically analyzed by
the χ2-method. Signiﬁcant differences of wild-type vs. ArKO and ArKO vs.
ArKO/bsArTG are shown (*p <0.05).
brain-speciﬁcally transcribed from exon 1f (Honda et al., 1994,
1996). The promoter region of exon 1f is thought to be responsible
for the brain (preoptic area, medial hypothalamus, and amyg-
dala regions)-speciﬁc, the neuron-speciﬁc, and the developmental
stage-speciﬁc expression in the brain (Harada and Honda, 2005).
Such a spatiotemporal expression of aromatase in the brain is
thought to be in line with the need for organization and acti-
vation of sexual behavior through local production of estrogens
in speciﬁc regions of the brain. In a previous study, the −6.5-
kb promoter region of exon 1f exhibited a similar pattern of
spatiotemporal expression as a LacZ reporter transgene in the
transgenic mouse and as expression of aromatase in the mouse
brain (Harada and Honda, 2005). All transgenic mice carrying
the transgene with the –6.5 kb promoter region showed signiﬁ-
cant β-galactosidase reporter activity, mainly in the limbic cortex
containing the amygdala and in the diencephalon containing the
preoptic area andmedial hypothalamus, similar to the localization
of aromatase in the mouse brain. There was almost no activity in
other tissues (Harada and Honda, 2005). Furthermore, the LacZ
transgene in all the transgenicmice showed a very similar develop-
mental expression pattern as that of mouse brain aromatase with
a transient peak during the perinatal period in the diencephalic
and limbic regions (Harada and Honda, 2005).
To elucidate the physiological functions of aromatase, we gen-
erated ArKO mice by targeted disruption of the mouse aromatase
gene (Honda et al., 1998). The ArKO mice show a complete deﬁcit
of estrogens and exhibit various abnormalities in the gonads,
bones, blood vessels, brain, etc. With regard to physiological
functions in the brain, the ArKO mice exhibited abnormal behav-
iors, such as a propensity for infanticide, inversion of aggressive
behaviors, and impairments in sexual motivation, partner pref-
erence, and performance behaviors and parental and exploratory
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FIGURE 5 |Typical locomotive activities of the wild-type and ArKO mice
aged 15weeks in open field tests.The locomotive behaviors of wild-type
and ArKO mice were monitored in the open ﬁeld cage (53 cm long×35 cm
wide×30 cm high) by a video-recorder with infrared night scope. Time-series
data of wild-type (A) and ArKO (B) mice were collected at 200ms intervals for
15min.
FIGURE 6 | Impairment and restoration of locomotive activities of
wild-type, ArKO, and ArKO/bsArTG mice.The travel distance and resting
time during a 15-min open ﬁeld test were analyzed from video-recorded
locomotor activities of males (hatched bars) and females (open bars) of
wild-type (n=9), ArKO (n=11), and ArKO/bsArTG (n=9) mice aged
14–16weeks.
behaviors (Bakker et al., 2002a,b; Aste et al., 2003; Matsumoto
et al., 2003a,b). The observation on the sexual behaviors is con-
sistent with phenotypes of αβERKO mice in principle (Ogawa
et al., 2000). The αERKO males showed normal levels of mounts
and reduced levels of intromissions, but virtually no ejaculation
(Ogawa et al., 1997; Wersinger et al., 1997), whereas all three
components of sexual behaviors are normal in βERKO animals
(Ogawa et al., 1999). The αβ ERKO males did not exhibit any sex-
ual behaviors. Immunoreactive ERs were also reported to increase
approximately twofold in certain hypothalamic and limbic regions
of ArKO mice (Agarwal et al., 2000). The facts that estrogen deﬁ-
ciency in the ArKO mouse resulted in apoptosis of neurons in cer-
tain brain regions (Hill et al., 2007a, 2009) may suggest important
roles for estrogens in the formation of neuronal networks.
To date, ArKO mice have been generated in different labora-
tories, and independently observed to exhibit similar disorders in
sexual partner preference (Bakker et al., 2002b), sexual perfor-
mance, aggressive behavior (Toda et al., 2001a,b), and compul-
sive behavior (Hill et al., 2007b). The impairment in mounting
FIGURE 7 |The parallelism index of wild-type, ArKO, and ArKO/bsArTG
mice as a parameter of locomotor activity.The parallelism index, a
characteristic feature of locomotor or exploratory movement, was
calculated from video-recorded locomotor activities of males (hatched bars)
and females (open bars) of wild-type (n=9), ArKO (n=11), and
ArKO/bsArTG (n=9) mice aged 14–16weeks using behavioral analysis
software SMART (B). The index value elicited from the formula shown in
the (A) approaches +1 when the movement is straight ahead, and
approaches 0 and −1 when the test mouse moves rightward/leftward, and
backward, respectively.
behavior of ArKO males was reversed by repeated injection of
E2 when initiated on the day of birth, but not when treatment
was initiated on the 15th-day after birth (Toda et al., 2001a),
whereas Bakker et al. (2004) have reported that the deﬁcits in
sexual behaviors of ArKO males were largely corrected following
adult treatment with E2 benzoate. ArKOmales also showed signif-
icantly abnormal aggressive behaviors, compared with wild-type
males (Matsumoto et al., 2003a,b). Supplements of E2 soon after
birth reportedly restore a complete loss of male aggressive behavior
(Toda et al., 2001b).
The aromatase gene with a brain-speciﬁc promoter was intro-
duced into the ArKO mice. Thus, aromatase in the ArKO/bsArTG
mice was expressed only in the brain with a transient peak
during the perinatal period, but not in other tissues includ-
ing gonadal tissues (Figure 1). The ArKO/bsArTG mice showed
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signiﬁcant recovery from impaired behaviors, suggesting that
aromatase in the brain played an important role in the organi-
zation effect through local estrogen production. However, sev-
eral behaviors such as mount, intromission, and aggression were
incompletely recovered by the transgenic aromatase introduced in
theArKO/bsArTGmice. The facts suggest that the activation effect
of these behaviors in adulthood would be exerted by high levels of
estrogen from both of the brain and gonadal tissues and estrogen
only from the brain in the ArKO/bsArTG mice is not enough to
bring about the same effect. Alternatively, redundant or paratac-
tic innervation systems by androgen or the other factors may also
function in the organization and activation effects. The additional
experiments using conditional knockout of ArKO and ArKO/bs
ArTG mice and E2 implantation might provide a clear answer.
Several lines of evidence indicate that androgens directly induce
male-typical aggressive behaviors (Svare and Gandelman, 1975;
Simon et al., 1985). Recent experiments using the Cre-loxP sys-
tem to generate ArKO male and female mice showed that ArKO
males exhibited no male-typical sexual and aggressive behaviors,
whereas ArKO females exhibited normal sexual behaviors (Sato
et al., 2004). Moreover, administration of non-aromatized andro-
gen, DHT to ArKO males was ineffective in restoring impaired
sexual behaviors, but it was partially effective in restoring impaired
aggressive behaviors,whereas DHT rescued impairedmale-typical
behaviors in ERKO mice (Sato et al., 2004).
Androgenmetabolites such as 5-androsten-3β, 17β-diol, and 5-
androtan-3β, 17β-diol were also characterized as ligands of ER in
the brains (Lund et al., 2006; Jellinck et al., 2007). 5-Androsten-3β,
17β-diol, a steroid with both of estrogenic and androgenic prop-
erties, has previously been shown to promote not only human
prostate cancer cells (Miyamoto et al., 1998) but also estrogen-
dependent breast cancer cells (Poulin and Labrie, 1986) and to act
as a ligand with a high afﬁnity for ER (Poulin and Labrie, 1986). It
has been found recently that it can also bemetabolized fromDHEA
by microglia (Jellinck et al., 2007). Neurons in the hypothala-
mus signiﬁcantly expressed ERβ,AR, andDHT, and its metabolite,
5-androstan-3β, 17β-diol functions in the stress-response by act-
ing through ERβ-expressing neurons (Lund et al., 2006). The
expression of all steroid-metabolizing enzymes of 5α-reductase,
17β-HSD, 3α-HSD, 3β-HSD, and aromatase in the hypothalamus
was demonstrated by RT–PCR (Lund et al., 2006). The conversion
of DHEA and DHT to 5-androsten-3β, 17β-diol and 5-androtan-
3β, 17β-diol, respectively, would be readily catalyzed by 3β-HSD
and 17β-HSD in the hypothalamus. These metabolites are non-
aromatized steroids derived from androgens and therefore would
also be produced in the brain of ArKO mice with elevated serum
levels of androgens, which were observed in all cases of indepen-
dently generated ArKO mice. To make clear whether these andro-
gen metabolites actually act as functional steroids in the brain, the
expression of steroid-metabolizing enzymes must be conﬁrmed
to elucidate metabolic proﬁles and local concentrations of neu-
rosteroids in the speciﬁc brain regions of wild-type, ArKO, and
ArKO/bsArTG mice. In this study, the brain-speciﬁc expression
of aromatase in the ArKO/bsArTG mice was veriﬁed (Figure 1).
Considering a post-translational modiﬁcation of aromatase such
as phosphorylation (Balthazart et al., 2005) and autophagy degra-
dation (Zhang et al., 2010) and an estrogenic action of androgen
metabolites (Poulin and Labrie, 1986; Miyamoto et al., 1998), it
will also be necessary to further determine the catalytic aromatase
activity and the local estrogen concentration in the speciﬁc brain
regions of wild-type, ArKO, and ArKO/bsArTG mice.
So far, there have been reports of aromatase/E2/ER-mediated,
5α-reducatase/DHT/AR-mediated,and androgenmetabolites/ER-
mediated innervation of areas implicated in the control of sex-
ual behaviors. Although this study provided evidence in support
of aromatase/E2/ER-mediated innervation of some behaviors,
the other behaviors were partially impaired in the ArKO mice
and partially recovered in the ArKO/bsArTG mice. The intro-
duction of ArTG into ArKO males led to complete recovery of
the abnormal ejaculation, aggressiveness to the intruder females,
and infanticide in the ArKO males, and only partial recovery of
abnormal mount and intromission behaviors in the ArKO males.
These facts may suggest the presence of redundant or paratac-
tic innervation system which could bypass or compensate for the
aromatase/E2/ER-mediated innervation.
We observed the undetectable serum levels of E2 and the
increased serum levels of T in the ArKO mice. These facts cast
doubt on the side effects resulting from elevated androgens with
respect to the abnormal behaviors observed in the ArKO mice
because androgens were reported to induce male-typical aggres-
sive behaviors (Svare and Gandelman, 1975; Simon et al., 1985)
and sexual behaviors (Sato et al., 2004). Thus,wedesigned recovery
experiments for behavioral disorders in ArKO mouse by intro-
duction of the aromatase transgene, regulated by the −6.5-kb
brain-speciﬁc promoter of the exon 1f, into the ArKO mouse.
Because the resulting ArKO/bsArTG mice express aromatase only
in the brains with a transient peak during the perinatal period,
adult ArKO/bsArTG mice showed almost the same serum levels
of E2 and T as adult ArKO mice. However, ArKO/bsArTG mice
nearly recovered from impairments of sexual behaviors includ-
ing mounting, intromission, and ejaculation behaviors observed
in the ArKO mice. Similarly, both the aggressive behavior and
the infanticide behavior observed in ArKO males were normal-
ized in the ArKO/bsArTG males. ArKO/bsArTG mice also showed
good recovery of locomotor (exploratory) activities measured by
travel distance, resting time, and the parallelism index. The results
obtained in this study support the supposition that estrogens pro-
duced in localized brain areas during the perinatal period may
directly act on the neurons and be essential for organization
of various behaviors in the brain, and that aromatase may play
an important role in the biological processes underlying brain
functions. To evaluate the accurate physiological function of 5-
androsten-3β, 17β-diol, 5-androtan-3β, 17β-diol, and the other
androgen metabolites in the brain, we would need to establish
the generation of steroid 17α, 20-lyase deﬁcient mouse maintain-
ing steroid 17α-hydroxylase activity as reported as a case of the
human genetic disease (Zachmann et al., 1982), and to analyze
behavioral disorders of steroid 17α, 20-lyase knockout mice and
restoration of the impairments by administration of estrogens,
androgens, and their metabolites.
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